US3926723A - Method of controllably releasing glucose to a cell culture medium - Google Patents

Method of controllably releasing glucose to a cell culture medium Download PDF

Info

Publication number
US3926723A
US3926723A US495609A US49560974A US3926723A US 3926723 A US3926723 A US 3926723A US 495609 A US495609 A US 495609A US 49560974 A US49560974 A US 49560974A US 3926723 A US3926723 A US 3926723A
Authority
US
United States
Prior art keywords
glucose
improvement
serum
culture medium
glucosidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US495609A
Inventor
Howard Green
James G Rheinwald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Priority to US495609A priority Critical patent/US3926723A/en
Application granted granted Critical
Publication of US3926723A publication Critical patent/US3926723A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Definitions

  • a cell culture medium which contains secondary sources of glucose comprising glucosecontaining oligosaccharides or polysaccharides and hydrolytic enzymes (glucosidases) to liberate free glucose.
  • Starch for example, can be added to a culture medium to provide the controlled release of glucose when a serum supplement such as fetal calf serum, which contains the hydrolytic enzymes amylase and maltase, is used.
  • Amylase breaks the starch down into glucose and maltose, and maltase converts the remaining maltose to glucose.
  • the rate of glucose release can be controlled by regulating the amount of glucosidase activity present in the medium.
  • Mammalian cells are typically grown in a culture medium to which a serum supplement is added.
  • culture media including Eagles medium, the Dulbecco-Vogt modification of Eagles medium, and Hams medium. In general, these are synthetic formulations designed to. provide sources of amino acids, vitamins, glucose, etc. to the growing cells.
  • the serumv supplement is added to provide certain proteins to the culture, and typical serum supplements include calf serum, fetal calf serum, and horse serum.
  • glucose is still the sugar mostly widely used in mammalian cell cultures, although it has been noted that cell growth could take place on maltose or glycogen after their hydrolysis by enzymes of embryo extract or serum. See Harris, M. and Kutsky, P. B., J. Cell Comp. PhysioL, 42, 449 (1953).
  • glucose in culture media does cause some problems, however. The most serious of these is that the glucose is consumed rapidly. Since cells cannot survive when their glucose supply has been exhausted, frequent refeeding to replenish the supply is necessary.- Further, high concentrations of glucose are not used efficiently by growing cells because the cells ferment more glucose than they can oxidize. This results in an accumulation of lactic acid, a fermentation product, in the medium which produces a concomitant drop in pH which is deleterious to cell growth. See Ceccarini, C. and Eagle, I-I., Proc. Nat. Acad. Sci. USA, 68, 229 (1971).
  • the invention comprises the use of secondary sources of glucose in cell culture media,
  • Suitable secondary sources of glucose include either a glucose-containing oligosaccharide or polysaccharide and a glucosidase, or enzyme capable of releasing glucose from the glucose-containing compounds.
  • Suitable glucosidase activity can be provided by choosing serum supplement containing the desired hydrolytic enzyme or'enzymes. Alternatively, commercial preparations of a glucosidase can be added to the culture medium.
  • the rate of glucose release to the culture medium can be controlled by adjusting the glucosidase activity present.
  • the rate can be reduced by partially inactivating the glucosidase activity in the serum supplement by heating the serum to an elevated temperature prior to its addition to the culture medium.
  • hydrolytic enzymes can be added to culture media to adjust the glucosidase activity to the desired level for any specific oligosaccharide or polysaccharide.
  • glucose is starch together-with the hydrolytic enzymes amylase and maltase.
  • the amylase breaks starch down to predominantly maltose units and the maltase completes the hydrolysis to glucosel
  • Another secondary source is the sugar maltose which is hydrolyzed by the enzyme maltase.
  • glucose is released by both systems.
  • a primary advantage is that any desired rate of glucose release to the cell culture medium can be achieved for extended periods of time. Low concentrations of glucose cannot be maintained by direct addition because the growing cells consume the glucose so rapidly. In the new system, glucose continues to be available to the cells at a time when it would have been exhausted if supplied to the medium directly.
  • FIG. 1 illustrates graphically the growth rate of established mammalian cell lines at various glucose concentrations.
  • FIG. 2 illustrates graphically the efficiency of cell utilization of glucose at different concentrations
  • FIG. 3 illustrates graphically the release of glucose from the secondary source starch using fetal calf serum which contains amylase and maltase;
  • FIG. 4 illustrates graphically the inactivation of serum enzymes with heat
  • FIG. 5 illustrates graphically certain conditions resulting from the growth of V79 cells in various culture media containing glucose, starch, plus amylase or maltose plus maltase;
  • FIG. 6 illustrates graphically the growth of V79 cells on maltose in a culture medium containing serum with maltase inactivated by heat.
  • Secondary glucose sources can be added to a wide variety of cell culture media.
  • Some of the better known and widely used media include Eagles medium, the Dulbecco-Vogt modification of Eagless medium, and Hams medium. It should be clear, however, that other media known to those skilled in the art can be provided with secondary glucose sources as described herein.
  • Suitable secondary sources of glucose can be a glucose-containing oligosaccharide or polysaccharide together with appropriate glucosidase activity.
  • the release of glucose can be illustrated for the oligosaccharide maltose used in combination with the enzyme maltase as follows:
  • Glucose Amylase hydrolyzes starch to glucose and maltose, and the maltose is hydrolyzed into glucose by the enzyme maltase. Itis preferable, therefore, to include both amylase and maltase in a culture medium if starch is the secondary source of glucose.
  • All glucose-containing oligosaccharides or polysaccharides which, can be broken down to release glucose by an appropriate glucosidase are suitable secondary sources.
  • oligosaccharides containing glucose include, but are not limited to, maltose, sucrose, lactose, and raffinose.
  • glucosecontaining polysaccharides include, but are not limited to glycogen and starch.
  • Other compounds containing glucosyl moiety which can be released may also be useful. These include, for example, synthetically prepared glucosides.
  • FIG. 1 illustrates how the doubling time of a number of established mammalian cell lines in the Dulbecco-Vogt modification of Eagles medium CH OH Glucose supplemented with l0% dialyzed calf serum or fetal calf serum depends on the glucose concentration of the medium. These determinations were carried out by inoculating 32 mm petri dishes with or 10 cells in 2.0 ml of medium and counting the number of cells per culture at daily intervals.
  • the doubling times taken from the exponential portion of the growth curves are independent of glucose concentration at the physiological range (1 mg/ml) or higher. Below 300 ,ug/ml the growth rates decline; but even at 1 pg/ml, a glucose concentration 1,000 fold lower than physiological, two of the lines grow with a doubling time of less than 50 hours without any initial delay attributable to adaptation. At still lower glucose concentrations, cell number does not increase and there is noticeable cell death and detachment. From these experiments, it can be seen that the preferred glucose concentration in a mammalian cell medium is from about one microgram to about 100 micrograms per milliliter of medium. Mass cultures can be grown indefinitely generations) at these glucose concentrations if the cell number is kept low and the cultures transferred before the glucose is consumed.
  • FIG. 2 shows the number of cells grown per unit of glucose consumed at varying glucose concentrations. Cultures with different initial glucose concentrations were formed by inoculating petri dishes containing 2.0 ml of Dulbecco-Vogt modification of Eagles medium and 10% dialyzed calf serum with 10" cells which were allowed to grow to maximal cell density. This density was attained when all the glucose was consumed. These cultures were not refed. Ordinate values were derived from the ratio,
  • the number of cells produced is 5-20 fold greater than at the physiological concentration of about 1 mg/ml.
  • the maximum cell number in fetal calf serum is 20-40% higher than in calf serum.
  • FIGS. 1 and 2 Doubling times and maximal cell density in low glucose concentrations were estimated for FIGS. 1 and 2 as follows. Subconfluent, growing cultures in medium containing 4.5 mg/ml glucose and 10% calf serum were removed with isotonic EDTA and trypsin, diluted into glucose-free medium for counting, then centrifuged and resuspended in fresh glucose-free medium. 10 or 10 cells were plated in duplicate 32 mm dishes containing 2.1 ml of medium with 10% dialyzed calf serum and different glucose concentrations. Beginning two to four days later, cultures were trypsinized and the cells were counted daily until the cultures failed to increase in cell number and began to degenerate due to glucose starvation.
  • One method of conveniently adding the appropriate glucosidase to a culture medium is to select a serum supplement which contains the desired hydrolytic enzyme activity.
  • different types of serum contain differing types and amounts of enzyme activity.
  • calf serum has been found to have threefold greater activity of a-amylase than fetal calf serum, whereas horse serum has less than 10% of the activity of fetal calf serum. Because of these differences, a convenient method of controlling the amount of any particular glucosidase activity in the culture is to select a serum containing the particular enzyme activity desired and to add the serum in an amount sufficient to provide the desired level of activity.
  • a serum having too high an activity for example, can be heated to an elevated temperature and cooled prior to its addition to the culture medium to provide the desired activity level.
  • EXAMPLE 1 Digestion of Starch and Liberation of Glucose by Enzymes of Fetal Calf Serum under Cell Culture Conditions A 10% stock solution of starch was prepared by dissolving 5 grams of soluble starch, B grade (Calbiochem) in 50 nil of glass distilled water by heating for about 30 minutes in a boiling water bath, and then autoclaving for 15 minutes at 25 psi.
  • Glucose and starch determinations were done as follows.
  • the glucose oxidase reaction coupled with the oxidation of a chromogen (Glucostat special, Worthington Biochemical Corp.) gives a -yellow-brown color with maximum absorption at 400 nm.
  • a chromogen Glucostat special, Worthington Biochemical Corp.
  • 0.6 ml of diluted unknowns, standards and a glucose-free blank were deproteinized by the successive additions of 0.3 ml of 2% ZnSO .7H O and 0.3 ml 0.46% NaOH and centrifuged at 4,000 g for 10 min.
  • Equal volumes of the supernatant and glucostat reagent were mixed and incubated at 37C.; the reaction was stopped by the addition of two drops of 4.0 N HCl.
  • the length of incubation with the glucostat reagent was adjusted to make the absorption of the standard solutions proportional to their glucose concentration in the range of interest.
  • Iodine reagent was prepared by adding 18 mg iodine dissolved in 1 ml ethanol, to 320 ml of 3.5 mM K]. Concentrated HCl was added to a concentration of 0.01 N. The reagent was stored in a brown bottle and was prepared fresh every other day. Starch solutions were diluted from 1:1 to 1:40 in iodine reagent so as to give absorption proportional to starch concentration over a range of 20 pg-S mg perml. The
  • This serum supported growth as well as undialyzed serum, but glucose-free Dulbecco-Vogt medium could not substitute for Hams medium in the final dialysis without reduction in growth rate and cloning efficiency.
  • the level of glucose in the dialyzed serum was below the limit of detection by the glucose oxidase assay l ug/ml).
  • the serum was sterilized by filtration before use.
  • FIG. 4 shows that the ability to release glucose from starch was virtually completely lost after heating at 65C. for 90 min. The maltase activity was more resistant; its inactivation required 30 min. at 70C. In the absence of serum, the glucose oxidase assay of'a 5 mg/ml maltose solution gave a value of 4 ug/ml of glucose equivalent; this may represent contaminating glucose. 9
  • V79 cells 5x10 were inoculated into 32 mm petri dishes containing 2.0 ml of glucose-free Dulbecco- Vogt modification of Eagles medium. 4.5 mg/ml of either starch, maltose or glucose were added.
  • V79 cells grew on glucose liberated from starch or maltose by the enzymes of fetal calf serum with virtually no initial period of glucose starvation as shown in the upper panel of FIG. 5.
  • the growth curves of V79 cells in starch, maltose or glucose were virtually identical, the doubling time being about 12 hours.
  • the middle panel of FIG. 5 shows that cells grown in free glucose consumed nearly 90% of the added glucose in ten days. Glucose liberated from maltose or starch by the serum was not appreciably consumed by the cells for the first three days, but thereafter the increased cell number reduced the glucose concentration to very low levels, production and consumption presumably continuing concurrently.
  • the bottom panel of FIG. 5 shows how the pH of the medium was affected by the source of glucose in the culture.
  • the pH eventually dropped below 6.6.
  • the pH fell very little; the final values were 7.0 for maltose and 7.1 for starch, scarcely lower than the starting-value. From this data, it is clear that at the lower glucose levels maintained by sustained release from starch or maltose, more efficient glucose utilization results in much less acid production.
  • EXAMPLE 5 Growth of V79 Cells on Reduced Initial Concentrations of Glucose and Maltose
  • the procedure of Example 4 was followed except that an initial concentration of glucose of 500 ug/ml was used, and a low initial concentration of maltase activity was established by using a fetal calf serum supplement consisting of 9 parts heat inactivated serum 30 minutes) and one part unheated serum.
  • the growth rate in added glucose was a little more rapid than in maltose as shown in the upper panel of FIG. 6.
  • the glucose was no longer detectable in the medium; cell number did not increase further, and two days later began to decline, due to cell death and detachment.
  • the maltose-grown cells reached a higher saturation density and remained healthy in appearance; free glucose could be detected in the medium throughout the experiment as shown in the bottom panel of FIG. 6.
  • V79 cells Growth of V79 Cells on Glucose Released From Glycogen by Amylase in Fetal Calf Serum V79 cells (10 were inoculated into culture media prepared as in Example 3 but substituting glycogen for starch. Each day the cultures were examined by microscope and it was observed that the cells grew at the same rate and to the same density as a culture containing glucose, but the medium did not become acidic.
  • hydrolytic enzyme comprises a glucosidase
  • polysaccharide comprises starch and said glucosidase comprises amylase and maltase.
  • polysaccharide comprises glycogen and said glucosidase comprises amylase and maltase.
  • said serum comprises fetal calf serum.
  • said serum comprises fetal calf serum.
  • amylase and maltase are supplied to said culture medium by adding fetal calf serum thereto.
  • glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
  • glucosidase is included in an amount suflicient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
  • hydrolytic enzyme comprises a glucosidase

Abstract

A cell culture medium is disclosed which contains secondary sources of glucose comprising glucose-containing oligosaccharides or polysaccharides and hydrolytic enzymes (glucosidases) to liberate free glucose. Starch, for example, can be added to a culture medium to provide the controlled release of glucose when a serum supplement such as fetal calf serum, which contains the hydrolytic enzymes amylase and maltase, is used. Amylase breaks the starch down into glucose and maltose, and maltase converts the remaining maltose to glucose. The rate of glucose release can be controlled by regulating the amount of glucosidase activity present in the medium.

Description

United States Patent [191 Green et al.
[ 1 Dec. 16, 1975 METHOD OF CONTROLLABLY RELEASING GLUCOSE TO A CELL CULTURE MEDIUM [75] Inventors: Howard Green, Brookline; James G.
Rheinwald, Cambridge, both of Mass.
[73] Assignee: Massachusetts Institute of Technology, Cambridge, Mass.
[22] Filed: Aug. 8, 1974 [21] Appl. No.: 495,609
OTHER PUBLICATIONS Chem. Abstracts 76:1 37424(e). Chem. Abstracts 48:4080h.
Parker, Methods of Tissue Culture, 3 ed., Harper & Row, 1961, pp. 215-217.
Primary ExaminerA. Louis Monacell Assistant ExaminerThomas G. Wiseman Attorney, Agent, or FirmArthur A. Smith, Jr.; Martin M. Santa; David E. Brook ABSTRACT A cell culture medium is disclosed which contains secondary sources of glucose comprising glucosecontaining oligosaccharides or polysaccharides and hydrolytic enzymes (glucosidases) to liberate free glucose. Starch, for example, can be added to a culture medium to provide the controlled release of glucose when a serum supplement such as fetal calf serum, which contains the hydrolytic enzymes amylase and maltase, is used. Amylase breaks the starch down into glucose and maltose, and maltase converts the remaining maltose to glucose. The rate of glucose release can be controlled by regulating the amount of glucosidase activity present in the medium.
23 Claims, 6 Drawing Figures DOUBLTNG TIME (hours) GLUCOSE CONCENTRATION NUMBER OF CELLS PRODUCED PER NANOGRAM 0F GLUCOSE CONSUMED I I l GLUCOSE CONCENTRATION (,u-g/ml') FIG. 2.
METHOD OF CONTROLLABLY RELEASING GLUCOSE TO A CELL CULTURE MEDIUM The invention herein described was made in the course of work performed with a grant from the Department of Health, Education and Welfare.
BACKGROUND OF THE INVENTION 1. Field of the Invention I The invention is in the field of biology, and more specifically in the field .of cell biology. v
2. Description of the Prior Art Mammalian cells are typically grown in a culture medium to which a serum supplement is added. There are several well known culture media including Eagles medium, the Dulbecco-Vogt modification of Eagles medium, and Hams medium. In general, these are synthetic formulations designed to. provide sources of amino acids, vitamins, glucose, etc. to the growing cells. The serumv supplement is added to provide certain proteins to the culture, and typical serum supplements include calf serum, fetal calf serum, and horse serum. i I
It has heretofore been common to provide relatively high concentrations of glucose, e.g., greater than about 1 mg/ml, in culture media to provide a source of carbon and energy to the growing cells. Utilization by mammalian cell cultures of sugars other than glucose has, however, been studied extensively. See, for example, Harris, M. and Kutsky, P. B., J. Cell Comp. PhysioL, 42,
449 (1953); Eagle, H., Barban, S., Levy, M., and- Schulz, H. 0., J. Biol, Chem., 233, 551 (1958); Bailey, J. M., Gey, G. 0., and Gey, M. K., J. Biol. Chem, 234, 1042 (1959); Baugh, C. L. and Tytell, A. A., Life Sciences, 6, 371 (1967); Martineau, R. Kohlbacher, M., Shaw, S. N., and Amos, H.', Proc. Nat. Acad, Sci. USA, 69, 3407 (1972); Kalckar', H. M. and Ullrey, D., Proc. Nat. Acad. Sci. USA, 70, 2502 (1973); and Paul, .I., In Cells and Tissues in Culture, Vol. 1, Willmer,E. N., ed., Academic Press, New York, 239 (1965). From such studies, it has been determined that mannose and fructose are metabolised rapidly, but galactose is utilized more slowly and produces less lactate. See Eagle, H. Barban, S., Levy, M. and Schulze, H. 0., J. Biol. Chem., 233, 551 (1958). In spite of these extensive studies,
glucose is still the sugar mostly widely used in mammalian cell cultures, although it has been noted that cell growth could take place on maltose or glycogen after their hydrolysis by enzymes of embryo extract or serum. See Harris, M. and Kutsky, P. B., J. Cell Comp. PhysioL, 42, 449 (1953).
The use of glucose in culture media does cause some problems, however. The most serious of these is that the glucose is consumed rapidly. Since cells cannot survive when their glucose supply has been exhausted, frequent refeeding to replenish the supply is necessary.- Further, high concentrations of glucose are not used efficiently by growing cells because the cells ferment more glucose than they can oxidize. This results in an accumulation of lactic acid, a fermentation product, in the medium which produces a concomitant drop in pH which is deleterious to cell growth. See Ceccarini, C. and Eagle, I-I., Proc. Nat. Acad. Sci. USA, 68, 229 (1971).
SUMMARY OF THE INVENTION In one embodiment, the invention comprises the use of secondary sources of glucose in cell culture media,
particularly those intended for mammalian cells. Suitable secondary sources of glucose include either a glucose-containing oligosaccharide or polysaccharide and a glucosidase, or enzyme capable of releasing glucose from the glucose-containing compounds. Suitable glucosidase activity can be provided by choosing serum supplement containing the desired hydrolytic enzyme or'enzymes. Alternatively, commercial preparations of a glucosidase can be added to the culture medium.
' The rate of glucose release to the culture medium can be controlled by adjusting the glucosidase activity present. For example, the rate can be reduced by partially inactivating the glucosidase activity in the serum supplement by heating the serum to an elevated temperature prior to its addition to the culture medium.
Alternatively, different amounts or types of hydrolytic enzymes, or serum supplements containing hydrolytic enzymes, can be added to culture media to adjust the glucosidase activity to the desired level for any specific oligosaccharide or polysaccharide.
One suitable secondary source of glucose is starch together-with the hydrolytic enzymes amylase and maltase. The amylase breaks starch down to predominantly maltose units and the maltase completes the hydrolysis to glucosel Another secondary source is the sugar maltose which is hydrolyzed by the enzyme maltase. Thus, glucose is released by both systems.
Providing glucose to culture media from secondary sources ofiers significant advantages over the direct addition of glucose. A primary advantage is that any desired rate of glucose release to the cell culture medium can be achieved for extended periods of time. Low concentrations of glucose cannot be maintained by direct addition because the growing cells consume the glucose so rapidly. In the new system, glucose continues to be available to the cells at a time when it would have been exhausted if supplied to the medium directly.
Supplying constant but relatively low levels of glucose to the cell culture from secondary sources also helps to maintain the pH of the culture medium within a beneficial range. This is primarily because little or no lactic acid is formed, since the growing cells metabolize completely the glucose liberated from the secondary source. Thus, the cells can be grown to a higher density and maintained healthier for longer periods of time than in media to which glucose is added directly, and frequent refeeding of cultures to supply glucose is eliminated.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 illustrates graphically the growth rate of established mammalian cell lines at various glucose concentrations.
FIG. 2 illustrates graphically the efficiency of cell utilization of glucose at different concentrations;
FIG. 3 illustrates graphically the release of glucose from the secondary source starch using fetal calf serum which contains amylase and maltase;
FIG. 4 illustrates graphically the inactivation of serum enzymes with heat;
FIG. 5 illustrates graphically certain conditions resulting from the growth of V79 cells in various culture media containing glucose, starch, plus amylase or maltose plus maltase;
FIG. 6 illustrates graphically the growth of V79 cells on maltose in a culture medium containing serum with maltase inactivated by heat.
DESCRIPTION OF THE PREFERRED EMBODIMENTS The provision of secondary glucose sources in culture media is useful in most cell cultures and is particu-. larly useful in mammalian cell cultures. Suchmammalian cells as 3T3 and 3T6 (mouse embryonic fibroblast lines), SVPy3T3-l 1, a 3T3 line doubly transformed by polyoma and SV40, human diploid fibroblasts, V79, (a line derived from Chinese hamster embryonic lung fibroblasts), and HeLa (human carcinona); as well as other mammalian cell lines can be grown in media containing secondary glucose sources.
Secondary glucose sources can be added to a wide variety of cell culture media. Some of the better known and widely used media include Eagles medium, the Dulbecco-Vogt modification of Eagless medium, and Hams medium. It should be clear, however, that other media known to those skilled in the art can be provided with secondary glucose sources as described herein.
Suitable secondary sources of glucose can be a glucose-containing oligosaccharide or polysaccharide together with appropriate glucosidase activity. The release of glucose can be illustrated for the oligosaccharide maltose used in combination with the enzyme maltase as follows:
Maltese Similarly, the release of glucose from the polysaccharide starch by the enzymes amylase and maltase can be illustrated as follows:
Glucose maltase; 2
Glucose Amylase hydrolyzes starch to glucose and maltose, and the maltose is hydrolyzed into glucose by the enzyme maltase. Itis preferable, therefore, to include both amylase and maltase in a culture medium if starch is the secondary source of glucose.
All glucose-containing oligosaccharides or polysaccharides which, can be broken down to release glucose by an appropriate glucosidase are suitable secondary sources. Examples of oligosaccharides containing glucose include, but are not limited to, maltose, sucrose, lactose, and raffinose. Suitable examples of glucosecontaining polysaccharides include, but are not limited to glycogen and starch. Other compounds containing glucosyl moiety which can be released may also be useful. These include, for example, synthetically prepared glucosides.
Secondary sources of glucose are particularly useful in cultures where it is desired to maintain a relatively constant but low concentration of glucose. Whereas most previous systems used glucose at the physiological range (1 mg/ml) or higher, it has been demonstrated that much lower concentrations can be used to achieve beneficial results. FIG. 1 illustrates how the doubling time of a number of established mammalian cell lines in the Dulbecco-Vogt modification of Eagles medium CH OH Glucose supplemented with l0% dialyzed calf serum or fetal calf serum depends on the glucose concentration of the medium. These determinations were carried out by inoculating 32 mm petri dishes with or 10 cells in 2.0 ml of medium and counting the number of cells per culture at daily intervals. The doubling times taken from the exponential portion of the growth curves are independent of glucose concentration at the physiological range (1 mg/ml) or higher. Below 300 ,ug/ml the growth rates decline; but even at 1 pg/ml, a glucose concentration 1,000 fold lower than physiological, two of the lines grow with a doubling time of less than 50 hours without any initial delay attributable to adaptation. At still lower glucose concentrations, cell number does not increase and there is noticeable cell death and detachment. From these experiments, it can be seen that the preferred glucose concentration in a mammalian cell medium is from about one microgram to about 100 micrograms per milliliter of medium. Mass cultures can be grown indefinitely generations) at these glucose concentrations if the cell number is kept low and the cultures transferred before the glucose is consumed.
The efficiency of glucose utilization is also improved by using lower glucose concentrations. This is illustrated in FIG. 2 which shows the number of cells grown per unit of glucose consumed at varying glucose concentrations. Cultures with different initial glucose concentrations were formed by inoculating petri dishes containing 2.0 ml of Dulbecco-Vogt modification of Eagles medium and 10% dialyzed calf serum with 10" cells which were allowed to grow to maximal cell density. This density was attained when all the glucose was consumed. These cultures were not refed. Ordinate values were derived from the ratio,
At l-3 mg/ml, the number of cells produced is 5-20 fold greater than at the physiological concentration of about 1 mg/ml. At all glucose concentrations, the maximum cell number in fetal calf serum is 20-40% higher than in calf serum.
Doubling times and maximal cell density in low glucose concentrations were estimated for FIGS. 1 and 2 as follows. Subconfluent, growing cultures in medium containing 4.5 mg/ml glucose and 10% calf serum were removed with isotonic EDTA and trypsin, diluted into glucose-free medium for counting, then centrifuged and resuspended in fresh glucose-free medium. 10 or 10 cells were plated in duplicate 32 mm dishes containing 2.1 ml of medium with 10% dialyzed calf serum and different glucose concentrations. Beginning two to four days later, cultures were trypsinized and the cells were counted daily until the cultures failed to increase in cell number and began to degenerate due to glucose starvation.
One method of conveniently adding the appropriate glucosidase to a culture medium is to select a serum supplement which contains the desired hydrolytic enzyme activity. As is known, different types of serum contain differing types and amounts of enzyme activity. For example, calf serum has been found to have threefold greater activity of a-amylase than fetal calf serum, whereas horse serum has less than 10% of the activity of fetal calf serum. Because of these differences, a convenient method of controlling the amount of any particular glucosidase activity in the culture is to select a serum containing the particular enzyme activity desired and to add the serum in an amount sufficient to provide the desired level of activity. Alternatively, another convenient method for reducing the rate of hydrolysis is to use heat to inactivate part of the enzymatic-activity. A serum having too high an activity, for example, can be heated to an elevated temperature and cooled prior to its addition to the culture medium to provide the desired activity level.
The invention is further illustrated by the following examples:
EXAMPLE 1 Digestion of Starch and Liberation of Glucose by Enzymes of Fetal Calf Serum under Cell Culture Conditions A 10% stock solution of starch was prepared by dissolving 5 grams of soluble starch, B grade (Calbiochem) in 50 nil of glass distilled water by heating for about 30 minutes in a boiling water bath, and then autoclaving for 15 minutes at 25 psi.
One part of the stock starch solution was introduced into 20 parts of serum-free, Dulbecco-Vogt modification of Eagle s medium. The medium was maintained at 37C. for over 20 days, after which time there was no detectable decline in the amount of starch and no liberation of glucose.
The same procedure was followed except substituting medium containing 10% fetal calf serum. This time, starch disappeared with a half-life of about 35 minutes and was near the limit of detection 4 hours later. Glucose appeared in the medium, but less rapidly, since molecules containing fewer than 8 saccharide units give no color in the starch-iodine reaction, but must be further hydrolyzed to yield glucose. The glucose concentration in the medium reached 25 ag/ml within an hour, a concentration fully able to support cell growth. The concentration rose to pig/ml by four hours, and continued to rise until, by about 10 days, a maximum of about 50% of the starch was converted to glucose.
Glucose and starch determinations were done as follows. The glucose oxidase reaction, coupled with the oxidation of a chromogen (Glucostat special, Worthington Biochemical Corp.) gives a -yellow-brown color with maximum absorption at 400 nm. 0.6 ml of diluted unknowns, standards and a glucose-free blank were deproteinized by the successive additions of 0.3 ml of 2% ZnSO .7H O and 0.3 ml 0.46% NaOH and centrifuged at 4,000 g for 10 min. Equal volumes of the supernatant and glucostat reagent were mixed and incubated at 37C.; the reaction was stopped by the addition of two drops of 4.0 N HCl. The length of incubation with the glucostat reagent was adjusted to make the absorption of the standard solutions proportional to their glucose concentration in the range of interest. The assay was accurate over a range of 1 pg/ml to 5 mg/ml.
A modification of the iodine method of Smith and Roe (1949) was used. Iodine reagent was prepared by adding 18 mg iodine dissolved in 1 ml ethanol, to 320 ml of 3.5 mM K]. Concentrated HCl was added to a concentration of 0.01 N. The reagent was stored in a brown bottle and was prepared fresh every other day. Starch solutions were diluted from 1:1 to 1:40 in iodine reagent so as to give absorption proportional to starch concentration over a range of 20 pg-S mg perml. The
color is stable for several hours at dilutions of 1:20 or 1:40 of sample to reagent, but fades rapidly at 1:1 dilution.
The results of this Example are shown graphically in FIG. 3.
EXAMPLE 2 Inactivation of Serum Enzymes Liberating Glucose from Starch and from Maltose Glucose-free, fetal calf serum, which contains amylase and maltase, was heated in a water bath under various conditions and then tested for its ability to release glucose from starch. The serum was dialyzed at 4C. for 24 hours against three changes of 20 volumes of isotonic phosphate buffered salt solution (pH 7.3) and finally for -18 hrs. against 5 volumes of glucosefree F12 medium (Ham, 1965). This serum supported growth as well as undialyzed serum, but glucose-free Dulbecco-Vogt medium could not substitute for Hams medium in the final dialysis without reduction in growth rate and cloning efficiency. The level of glucose in the dialyzed serum was below the limit of detection by the glucose oxidase assay l ug/ml). The serum was sterilized by filtration before use.
FIG. 4 shows that the ability to release glucose from starch was virtually completely lost after heating at 65C. for 90 min. The maltase activity was more resistant; its inactivation required 30 min. at 70C. In the absence of serum, the glucose oxidase assay of'a 5 mg/ml maltose solution gave a value of 4 ug/ml of glucose equivalent; this may represent contaminating glucose. 9
EXAMPLE 3 Growth of V79 Cells on Starch or Maltose as Secondary Glucose Sources V79 cells (5x10 were inoculated into 32 mm petri dishes containing 2.0 ml of glucose-free Dulbecco- Vogt modification of Eagles medium. 4.5 mg/ml of either starch, maltose or glucose were added.
The V79 cells grew on glucose liberated from starch or maltose by the enzymes of fetal calf serum with virtually no initial period of glucose starvation as shown in the upper panel of FIG. 5. The growth curves of V79 cells in starch, maltose or glucose were virtually identical, the doubling time being about 12 hours.
The middle panel of FIG. 5 shows that cells grown in free glucose consumed nearly 90% of the added glucose in ten days. Glucose liberated from maltose or starch by the serum was not appreciably consumed by the cells for the first three days, but thereafter the increased cell number reduced the glucose concentration to very low levels, production and consumption presumably continuing concurrently.
The bottom panel of FIG. 5 shows how the pH of the medium was affected by the source of glucose in the culture. When the high concentration of free glucose was present from the outset, the pH eventually dropped below 6.6. In cultures containing secondary glucose sources, the pH fell very little; the final values were 7.0 for maltose and 7.1 for starch, scarcely lower than the starting-value. From this data, it is clear that at the lower glucose levels maintained by sustained release from starch or maltose, more efficient glucose utilization results in much less acid production.
EXAMPLE 5 Growth of V79 Cells on Reduced Initial Concentrations of Glucose and Maltose The procedure of Example 4 was followed except that an initial concentration of glucose of 500 ug/ml was used, and a low initial concentration of maltase activity was established by using a fetal calf serum supplement consisting of 9 parts heat inactivated serum 30 minutes) and one part unheated serum. Under these conditions, the growth rate in added glucose was a little more rapid than in maltose as shown in the upper panel of FIG. 6. By the fourth day, however, the glucose was no longer detectable in the medium; cell number did not increase further, and two days later began to decline, due to cell death and detachment. The maltose-grown cells reached a higher saturation density and remained healthy in appearance; free glucose could be detected in the medium throughout the experiment as shown in the bottom panel of FIG. 6.
EXAMPLE 6 Growth of V79 Cells on Glucose Released From Glycogen by Amylase in Fetal Calf Serum V79 cells (10 were inoculated into culture media prepared as in Example 3 but substituting glycogen for starch. Each day the cultures were examined by microscope and it was observed that the cells grew at the same rate and to the same density as a culture containing glucose, but the medium did not become acidic.
What is claimed is:
1. In the method of culturing mammalian cells in a culture medium which supplies nutrients including glucose to said mammalian cells:
The improvement of maintaining the glucose concentration in said culture medium at a desired concentration by providing sustained release of glucose at a controlled rate by including in the culture medium a compound containing an enzymaticallyreleasable glucosyl moiety and an enzyme activity capable of releasing glucose from said glucosylcontaining compound, said glucosyl-containing compound being present in an amount sufficient to provide sustained release of glucose and said enzyme activity being present at a level sufficient to maintain the glucose at the desired concentration.
2. The improvement of claim 1 wherein said enzyme activity is supplied by the presence in said culture medium of at least one hydrolytic enzyme.
3. The improvement of claim 2 wherein said hydrolytic enzyme comprises a glucosidase.
4. The improvement of claim 3 wherein said glucosylcontaining compound comprises an oligosaccharide.
5. The improvement of claim 4 wherein said oligosaccharide comprises maltose and said glucosidase comprises maltase.
6. The improvement of claim 3 wherein said glucosylcontaining compound comprises a polysaccharide.
7. The improvement of claim 6 wherein said polysaccharide comprises starch and said glucosidase comprises amylase and maltase.
8. The improvement of claim 6 wherein said polysaccharide comprises glycogen and said glucosidase comprises amylase and maltase.
9. The improvement of claim 1 wherein said enzyme activity is supplied to said culture medium by adding serum thereto.
10. The improvement of claim 9 wherein said serum comprises fetal calf serum.
11. The improvement of claim 5 wherein maltase is supplied to said culture medium by adding serum thereto.
12. The improvement of claim 11 wherein said serum comprises fetal calf serum.
13. The improvement of claim 7 wherein amylase and maltase are supplied to said culture medium by adding fetal calf serum thereto.
14. The improvement of claim 1 wherein said enzyme activity is included in an amount sufiicient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
15. The improvement of claim 4 wherein said glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
16. The improvement of claim 6 wherein said glucosidase is included in an amount suflicient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
17. The improvement of claim 9 wherein sufficient serum is added to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter.
10 activity in the serum added to said culture medium is reduced by heating the serum to an elevated temperature prior to its addition to the culture medium.
19. The improvement of claim 18 wherein said enzyme activity is supplied by the presence in said serum of at least one hydrolytic enzyme.
20. The improvement of claim 19 wherein said hydrolytic enzyme comprises a glucosidase.
21. The improvement of claim 20 wherein said serum comprises fetal calf serum.
23. The improvement of claim 22 wherein the glucosidase activity in said serum is reduced by heating said serum.

Claims (23)

1. IN THE METHOD OF CULTURING MAMMALIAN CELLS IN A CULTURE MEDIUM WHICH SUPPLIES NUTRIENTS INCLUDING GLUCOSE TO SAID MAMMALIAN CELLS: THE IMPROVEMENT OF MAINTAINING THE FLUCOSE CONCENTRATION IN SAID CULTURE MEDIUM AT A DESIRED CONCENTRATION BY PROVIDING SUSTAINED RELEASE OF FLUCOSE AT A CONTROLLED RATE BY INCLUDING IN THE CULTURE MEDIUM A COMPOUND CONTAINING AN ENZYMATICALLY-RELEASABLE GLUCOSYL MOIETY AND AN ENZYME ACTIVITY CAPABLE OF RELEASING GLUCOSE FROM SAID FLUCOSYL-CONTAINING COMPOUND, SAID FLUCOSYL-CONTAINING COMPOUND BEING PRESENT IN AN AMOUNT SUFFICIENT TO PROVIDE SUSTAINED RELEASE OF FLUCOSE AND SAID ENZYME ACTIVITY BEING PRESENT AT A LEVEL SUFFICIENT TO MAINTAIN THE FLUCOSE AT THE DESIRED CONCENTRATION.
2. The improvement of claim 1 wherein said enzyme activity is supplied by the presence in said culture medium of at least one hydrolytic enzyme.
3. The improvement of claim 2 wherein said hydrolytic enzyme comprises a glucosidase.
4. The improvement of claim 3 wherein said glucosyl-containing compound comprises an oligosaccharide.
5. The improvement of claim 4 wherein said oligosaccharide comprises maltose and said glucosidase comprises maltase.
6. The improvement of claim 3 wherein said glucosyl-containing compound comprises a polysaccharide.
7. The improvement of claim 6 wherein said polysaccharide comprises starch and said glucosidase comprises amylase and maltase.
8. The improvement of claim 6 wherein said polysaccharide comprises glycogen and said glucosidase comprises amylase and maltase.
9. The improvement of claim 1 wherein said enzyme activity is supplied to said culture medium by adding serum thereto.
10. The improvement of claim 9 wherein said serum comprises fetal calf serum.
11. The improvement of claim 5 wherein maltase is supplied to said culture medium by adding serum thereto.
12. The improvement of claim 11 wherein said serum comprises fetal calf serum.
13. The improvement of claim 7 wherein amylase and maltase are supplied to said culture medium by adding fetal calf serum thereto.
14. The improvement of claim 1 wherein said enzyme activity is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
15. The improvement of claim 4 wherein said glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
16. The improvement of claim 6 wherein said glucosidase is included in an amount sufficient to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter of medium.
17. The improvement of claim 9 wherein sufficient serum is added to maintain a glucose concentration in said culture medium of from about 1 to about 100 micrograms per milliliter.
18. The improvement of claim 9 wherein the enzyme activity in the serum added to said culture medium is reduced by heating the serum to an elevated temperature prior to its addition to the culture medium.
19. The improvement of claim 18 wherein said enzyme activity is supplied by the presence in said serum of at least one hydrolytic enzyme.
20. The improvement of claim 19 wherein said hydrolytic enzyme comprises a glucosidase.
21. The improvement of claim 20 wherein said serum comprises fetal calf serum.
22. In the method of growing mammalian cell cultures wherein serum containing glucasidase activity is added to a mammalian cell culture medium to release glucose from glucosyl-containing compound to maintain a desired glucose concentration: the improvement of regulating the glucose concentration in said culture medium by regulating the glucosidase activity of the serum prior to its addition to the culture medium.
23. The improvement of claim 22 wherein the glucosidase activity in said serum is reduced by heating said serum.
US495609A 1974-08-08 1974-08-08 Method of controllably releasing glucose to a cell culture medium Expired - Lifetime US3926723A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US495609A US3926723A (en) 1974-08-08 1974-08-08 Method of controllably releasing glucose to a cell culture medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US495609A US3926723A (en) 1974-08-08 1974-08-08 Method of controllably releasing glucose to a cell culture medium

Publications (1)

Publication Number Publication Date
US3926723A true US3926723A (en) 1975-12-16

Family

ID=23969285

Family Applications (1)

Application Number Title Priority Date Filing Date
US495609A Expired - Lifetime US3926723A (en) 1974-08-08 1974-08-08 Method of controllably releasing glucose to a cell culture medium

Country Status (1)

Country Link
US (1) US3926723A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230806A (en) * 1977-06-07 1980-10-28 Mitsui Engineering & Shipbuilding Co., Ltd. Process for the production of microbial protein and lipid from vegetable carbohydrates by culture of microbes
WO1987000195A1 (en) * 1985-06-28 1987-01-15 Celltech Limited Animal cell culture
US4937194A (en) * 1986-05-12 1990-06-26 Baxter International Inc. Method for metering nutrient media to cell culture containers
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US5856179A (en) * 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US6020148A (en) * 1992-02-04 2000-02-01 The Procter & Gamble Company In vitro method for eye and skin irritation testing
US20030087372A1 (en) * 2001-06-13 2003-05-08 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
EP1609853A1 (en) 1995-06-06 2005-12-28 F.Hoffmann-La Roche Ag Process for controlling sialylation of proteins produced by mammalian cell culture
WO2008065254A1 (en) 2006-11-30 2008-06-05 Oulun Yliopisto Method for controlling the growth of cell culture
EP2130906A1 (en) 2008-06-04 2009-12-09 BioSilta Oy Method for the supply of growth components to cell cultures
EP2226380A1 (en) 2009-03-05 2010-09-08 BioSilta Oy Enzyme-based fed-batch technique in liquid cultures
DE102010013852A1 (en) 2010-04-01 2011-10-06 M2P-Labs Gmbh Process for the process control of a reactant-limited, biochemical reaction
WO2016085787A1 (en) 2014-11-25 2016-06-02 Corning Incorporated Cell culture media extending materials and methods
US10501769B2 (en) 2009-10-26 2019-12-10 Hoffmann-La Roche Inc. Method for the production of a glycosylated immunoglobulin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658021A (en) * 1949-11-30 1953-11-03 Earle Wilton Robinson Single tissue cell culturing procedure
US2891869A (en) * 1953-06-03 1959-06-23 Staley Mfg Co A E Process for preparing starch syrups
US3128228A (en) * 1960-03-04 1964-04-07 Ustav Ser A Ockovacich Latek Tissue culture medium
US3242055A (en) * 1962-07-10 1966-03-22 Lucia Santo De Process and composition for enhancing bacterial action on septic tanks and the like, and method of making said composition
US3850748A (en) * 1973-06-28 1974-11-26 Lilly Co Eli Method of producing animal cells in suspension culture

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658021A (en) * 1949-11-30 1953-11-03 Earle Wilton Robinson Single tissue cell culturing procedure
US2891869A (en) * 1953-06-03 1959-06-23 Staley Mfg Co A E Process for preparing starch syrups
US3128228A (en) * 1960-03-04 1964-04-07 Ustav Ser A Ockovacich Latek Tissue culture medium
US3242055A (en) * 1962-07-10 1966-03-22 Lucia Santo De Process and composition for enhancing bacterial action on septic tanks and the like, and method of making said composition
US3850748A (en) * 1973-06-28 1974-11-26 Lilly Co Eli Method of producing animal cells in suspension culture

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230806A (en) * 1977-06-07 1980-10-28 Mitsui Engineering & Shipbuilding Co., Ltd. Process for the production of microbial protein and lipid from vegetable carbohydrates by culture of microbes
WO1987000195A1 (en) * 1985-06-28 1987-01-15 Celltech Limited Animal cell culture
GB2195655A (en) * 1985-06-28 1988-04-13 Celltech Ltd Animal cell culture
GB2195655B (en) * 1985-06-28 1989-10-25 Celltech Ltd Animal cell culture
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US4937194A (en) * 1986-05-12 1990-06-26 Baxter International Inc. Method for metering nutrient media to cell culture containers
US6020148A (en) * 1992-02-04 2000-02-01 The Procter & Gamble Company In vitro method for eye and skin irritation testing
US6180401B1 (en) 1994-03-10 2001-01-30 Genentech, Inc. Polypeptide production in animal cell culture
US5856179A (en) * 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US20040048368A1 (en) * 1994-03-10 2004-03-11 Genentech, Inc. Polypeptide production in animal cell culture
US20050272124A1 (en) * 1994-03-10 2005-12-08 Genentech, Inc. Polypeptide production in animal cell culture
EP1609853A1 (en) 1995-06-06 2005-12-28 F.Hoffmann-La Roche Ag Process for controlling sialylation of proteins produced by mammalian cell culture
US20030087372A1 (en) * 2001-06-13 2003-05-08 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
WO2008065254A1 (en) 2006-11-30 2008-06-05 Oulun Yliopisto Method for controlling the growth of cell culture
US9228167B2 (en) 2006-11-30 2016-01-05 Oulun Yliopisto Method for controlling the growth of cell culture
US20100099164A1 (en) * 2006-11-30 2010-04-22 Oulun Yliopisto Method for controlling the growth of cell culture
WO2009147200A3 (en) * 2008-06-04 2010-01-28 Biosilta Oy Method for the supply of growth components to cell cultures
WO2009147200A2 (en) * 2008-06-04 2009-12-10 Biosilta Oy Method for the supply of growth components to cell cultures
US20110244573A1 (en) * 2008-06-04 2011-10-06 Biosilta Oy Method For The Supply Of Growth Components To Cell Cultures
EP2130906A1 (en) 2008-06-04 2009-12-09 BioSilta Oy Method for the supply of growth components to cell cultures
AU2010220253B2 (en) * 2009-03-05 2016-02-25 Biosilta Oy Enzyme-based fed-batch technique in liquid cultures
EP2226380A1 (en) 2009-03-05 2010-09-08 BioSilta Oy Enzyme-based fed-batch technique in liquid cultures
WO2010100239A1 (en) 2009-03-05 2010-09-10 Biosilta Oy Enzyme-based fed-batch technique in liquid cultures
US9127261B2 (en) 2009-03-05 2015-09-08 Biosilta Oy Enzyme-based fed-batch technique in liquid cultures
US10501769B2 (en) 2009-10-26 2019-12-10 Hoffmann-La Roche Inc. Method for the production of a glycosylated immunoglobulin
US11021728B2 (en) 2009-10-26 2021-06-01 Hoffmann-La Roche Inc. Method for the production of a glycosylated immunoglobulin
US11136610B2 (en) 2009-10-26 2021-10-05 Hoffmann-La Roche Inc. Method for the production of a glycosylated immunoglobulin
US11377678B2 (en) 2009-10-26 2022-07-05 Hoffman-La Roche Inc. Method for the production of a glycosylated immunoglobulin
DE102010013852A1 (en) 2010-04-01 2011-10-06 M2P-Labs Gmbh Process for the process control of a reactant-limited, biochemical reaction
WO2016085787A1 (en) 2014-11-25 2016-06-02 Corning Incorporated Cell culture media extending materials and methods
EP3865563A1 (en) 2014-11-25 2021-08-18 Corning Incorporated Cell culture media extending materials and methods
US11932838B2 (en) 2014-11-25 2024-03-19 Corning Incorporated Cell culture media extending materials and methods

Similar Documents

Publication Publication Date Title
Rheinwald et al. Growth of cultured mammalian cells on secondary glucose sources
US3926723A (en) Method of controllably releasing glucose to a cell culture medium
Jeffrey et al. The role of ascorbic acid in the biosynthesis of collagen I. Ascorbic acid requirement by embryonic chick tibia in tissue culture
Green Cyclic AMP in relation to proliferation of the epidermal cell: a new view
Rutherford et al. Deficient heme synthesis as the cause of noninducibility of hemoglobin synthesis in a Friend erythroleukemia cell line
Ambrus et al. Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes
Vonderhaar et al. An early effect of prolactin on the formation of α-lactalbumin by mouse mammary epithelial cells
Briggs Origin and distribution of α‐amylase in malt
Ishihara et al. Correlations between heparan sulfate metabolism and hepatoma growth
Nagasawa et al. Factors influencing the induction of sister chromatid exchanges in mammalian cells by 12-O-tetradecanoyl-phorbol-13-acetate
Kaukel et al. Divergent action of cAMP and dibutyryl cAMP on macromolecular synthesis in HeLa S3 cultures
Harold et al. A genetic defect in retention of potassium by Streptococcus faecalis
Steck et al. Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus
Galun et al. Morphogenesis in Trichoderma: suppression of photoinduction by 5-fluorouracil
Breen et al. Respiration-deficient Chinese hamster cell mutants: biochemical characterization
Löffler On the role of dihydroorotate dehydrogenase in growth cessation of Ehrlich ascites tumor cells cultured under oxygen deficiency
Koyama et al. Further studies on the induction of alkaline phosphatase by 5-bromodeoxyuridine in a hybrid line between mouse and Chinese hamster in culture
Terracciano et al. Enhancement of chemotaxis in Spirochaeta aurantia grown under conditions of nutrient limitation
Storrie et al. The role of butyrate in the reverse transformation reaction in mammalian cells
Reuser et al. Adult forms of glycogenosis type II: A defect in an early stage of acid α-glucosidase realization
Bansal et al. Evidence for rapid metabolic turnover of hyaluronate synthetase in Swarm rat chondrosarcoma chondrocytes
Rein et al. On the survival of chick embryo cells at low concentrations in culture
Harris et al. Sequential induction of maltose-permease and maltase systems in Saccharomyces cerevisiae
Sens et al. Effects of pyruvate on the growth of normal and transformed hamster embryo fibroblasts
Nakamura et al. Hormonal control of the development of tryptophan oxygenase in primary cultures of young rat hepatocytes